Innocan Pharma Corp. buy Heisinger
Start price
17.09.21
/
50%
€0.89
Target price
17.09.22
-
Performance (%)
-55.14%
End price
19.05.22
€0.40
Summary
This prediction ended on 19.05.22 with a price of €0.40. The BUY prediction by Heisinger for Innocan Pharma Corp. performed very badly with a performance of -55.14%. Heisinger has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Innocan Pharma Corp. | - | - | - | - |
| iShares Core DAX® | 3.023% | 2.202% | 14.664% | 48.878% |
| iShares Nasdaq 100 | 3.561% | 1.325% | 31.410% | 83.744% |
| iShares Nikkei 225® | 6.618% | 5.707% | 49.420% | 60.392% |
| iShares S&P 500 | 2.635% | 1.008% | 25.116% | 61.272% |
Comments by Heisinger for this prediction
In the thread Innocan Pharma Corp. diskutieren
Buy Innocan Pharma Corp.